Neuron-specific delivery platform based on a chimeric toxin for botulism postexposure treatment Jan. 26, 2021
Selective PDEB inhibitor shows promising preclinical results for the treatment of cocaine addiction Oct. 9, 2020
Sobrera and Recipharm collaborate on formulation development of SO-001 for alcohol use disorder Sep. 29, 2020